Preparation and characterization of metformin hydrochloride loaded-Eudragit^®RSPO and Eudragit^®RSPO/PLGA nanoparticles

References

• Tahrani AA, Piya MK, Barnett AH. Drug evaluation: Vildagliptin-metformin single-tablet combination. Adv Ther 2009;26:138–154.
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation. Types of diabetes [Online] 2010. Available at: http://www.idf.org/types-diabetes. Accessed on 3 December 2010.
   Google Scholar
• Derosa G. Efficacy and tolerability of pioglitazone in patients with type 2 diabetes mellitus: Comparison with other oral antihyperglycaemic agents. Drugs 2010;70:1945–1961.
   PubMed Web of Science ®Google Scholar
• Hamnvik OP, McMahon GT. Balancing risk and benefit with oral hypoglycemic drugs. Mt Sinai J Med 2009;76:234–243.
   PubMedGoogle Scholar
• Medscape. Combination therapy for patients with type 2 diabetes: Overview of oral antidiabetic medications [Online] 2010. Available at: http://www.medscape.com/viewarticle/722513_3. Accessed on 3 December 2010.
   Google Scholar
• Piao J, Lee JE, Weon KY, Kim DW, Lee JS, Park JD et al. Development of novel mucoadhesive pellets of metformin hydrochloride. Arch Pharm Res 2009;32:391–397.
   PubMed Web of Science ®Google Scholar
• Corti G, Cirri M, Maestrelli F, Mennini N, Mura P. Sustained-release matrix tablets of metformin hydrochloride in combination with triacetyl-β-cyclodextrin. Eur J Pharm Biopharm 2008;68:303–309.
   PubMed Web of Science ®Google Scholar
• Sweetman S, ed. Martindale: The Complete Drug Reference. London: Pharmaceutical Press, Electronic version, 2007.
   Google Scholar
• Marathe PH, Wen Y, Norton J, Greene DS, Barbhaiya RH, Wilding IR. Effect of altered gastric emptying and gastrointestinal motility on metformin absorption. Br J Clin Pharmacol 2000;50:325–332.
   PubMed Web of Science ®Google Scholar
• Amorim MJ, Ferreira JP. Microparticles for delivering therapeutic peptides and proteins to the lumen of the small intestine. Eur J Pharm Biopharm 2001;52:39–44.
   PubMed Web of Science ®Google Scholar
• Galindo-Rodriguez SA, Allemann E, Fessi H, Doelker E. Polymeric nanoparticles for oral delivery of drugs and vaccines: A critical evaluation of in vivo studies. Crit Rev Ther Drug Carrier Syst 2005;22:419–464.
   PubMed Web of Science ®Google Scholar
• Gelperina S, Kisich K, Iseman MD, Heifets L. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am J Respir Crit Care Med 2005;172:1487–1490.
   PubMed Web of Science ®Google Scholar
• Jawahar N, Eagappanath T, Venkatesh N, Jubie S, Samanta MK. Preparation and characterisation of PLGA-nanoparticles containing an anti-hypertensive agent. Int J PharmTech Res 2009;1:390–393.
   Google Scholar
• Song X, Zhao Y, Hou S, Xu F, Zhao R, He J et al. Dual agents loaded PLGA nanoparticles: Systematic study of particle size and drug entrapment efficiency. Eur J Pharm Biopharm 2008;69:445–453.
   PubMed Web of Science ®Google Scholar
• Mundargi RC, Srirangarajan S, Agnihotri SA, Patil SA, Ravindra S, Setty SB et al. Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: Iin vitro and in vivo studies. J Control Release 2007;119:59–68.
   PubMed Web of Science ®Google Scholar
• Cetin M, Capan Y, Vural I, Dogan AL, Guc D, Hincal AA, Wehrlé P, Dalkara T. Preparation and characterization of bFGF and BSA loaded microspheres. J Drug Del Sci Tech 2005;15:371–375.
   Web of Science ®Google Scholar
• Porta V, Schramm SG, Kano EK, Koono EE, Armando YP, Fukuda K et al. HPLC-UV determination of metformin in human plasma for application in pharmacokinetics and bioequivalence studies. J Pharm Biomed Anal 2008;46:143–147.
   PubMed Web of Science ®Google Scholar
• International Conference on Harmonization (ICH), Q2b: Validation of analytical procedures: methodology. US FDA Federal Register, 1997;62:27463.
   Google Scholar
• Xie H, Smith JW. Fabrication of PLGA nanoparticles with a fluidic nanoprecipitation system. J Nanobiotechnology 2010;8:18.
   PubMedGoogle Scholar
• Muthu MS, Rawat MK, Mishra A, Singh S. PLGA nanoparticle formulations of risperidone: Preparation and neuropharmacological evaluation. Nanomedicine 2009;5:323–333.
   PubMed Web of Science ®Google Scholar
• Kuksal A, Tiwary AK, Jain NK, Jain S. Formulation and in vitro, in vivo evaluation of extended- release matrix tablet of zidovudine: Influence of combination of hydrophilic and hydrophobic matrix formers. AAPS PharmSciTech 2006;7:E1.
   PubMed Web of Science ®Google Scholar
• Rowe RC, Sheskey PJ, Owen SC. eds. Handbook of Pharmaceutical Excipients, London-Washington: Pharmaceutical Press and American Pharmacists Association, 2006:553–560.
   Google Scholar
• Fattal E, Quaglia F, Gupta P, Brazeau G. Biodegradable microparticles for the development of less-painful and less-irritating parenterals. In: Gupta P, Brazeau G, eds. Injectable Drug Development: Techniques to Reduce Pain and Irritation. Informa Health Care, 1999:355–378.
   Google Scholar
• Valot P, Baba M, Nedelec JM, Sintes-Zydowicz N. Effects of process parameters on the properties of biocompatible ibuprofen-loaded microcapsules. Int J Pharm 2009;369:53–63.
   PubMed Web of Science ®Google Scholar
• Tunçay M, Calis S, Kas HS, Ercan MT, Peksoy I, Hincal AA. Diclofenac sodium incorporated PLGA (50:50) microspheres: Formulation considerations and in vitro/in vivo evaluation. Int J Pharm 2000;195:179–188.
   PubMed Web of Science ®Google Scholar
• Song X, Zhao Y, Wu W, Bi Y, Cai Z, Chen Q et al. PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: Systematic study of particle size and drug entrapment efficiency. Int J Pharm 2008;350:320–329.
   PubMed Web of Science ®Google Scholar
• Pandit SS, Hase DP, Bankar MM, Patil AT, Gaikwad NJ. Ketoprofen-loaded Eudragit RSPO microspheres: An influence of sodium carbonate on in vitro drug release and surface topology. J Microencapsul 2009;26:195–201.
   PubMed Web of Science ®Google Scholar
• Patra CN, Kumar AB, Pandit HK, Singh SP, Devi MV. Design and evaluation of sustained release bilayer tablets of propranolol hydrochloride. Acta Pharm 2007;57:479–489.
   PubMedGoogle Scholar
• Bozkir A, Saka OM. Formulation and investigation of 5-FU nanoparticles with factorial design-based studies. Farmaco 2005;60:840–846.
   PubMedGoogle Scholar
• Dillen K, Vandervoort J, Van den Mooter G, Ludwig A. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles. Int J Pharm 2006;314:72–82.
   PubMed Web of Science ®Google Scholar